TNF and Alzheimer disease: Pilot studies reported improvement in efficacy variables with treatment with etanercept, a TNF‐alpha inhibitor in patients with AD,220, 221 while a double‐blind phase II study observed no statistically significant changes in cognition, behavior, or global function.222